Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Licensing deals
Biotech
Alphabet's Calico weaves anti-aging deal with China's Mabwell
Alphabet’s Calico is inking a deal worth up to $571 million biobucks for rights to Mabwell's IL-11-targeting mAb for age-related diseases.
Gabrielle Masson
Jun 26, 2025 4:52pm
Fierce Pharma
Vor Bio's surprise $4B revival deal splits investor reactions
Jun 26, 2025 10:55am
Hummingbird uses VISTA buzz to secure $290M pact for tumor drug
Jun 26, 2025 4:53am
Arbutus regains China rights to potential hep B cure from Qilu
Jun 25, 2025 9:15am
Sanofi signs €545M deal to explore Formation’s JAK/SYK inhibitor
Jun 23, 2025 9:47am
Otsuka's $670M pact to point Harbour's TCE to autoimmune disease
Jun 23, 2025 6:29am
